Clinicopathological Significance of MTA 1 Expression in Patients with Non-Small Cell Lung Cancer: A Meta-Analysis
Conclusions: These results indicated that
MTA1 might be a valuable biomarker in the diagnosis of NSCLC. MTA1 overexpression was significantly associated
with age ≥60 years, gender, histopathological type, clinical grade (I-II), T stage (T1/T2) and lymph node positivity in
NSCLC patients.
PMID: 29172257 [PubMed]
Source: Asian Pacific Journal of Cancer Prevention - Category: Cancer & Oncology Tags: Asian Pac J Cancer Prev Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Carcinoma | China Health | Genetics | Lung Cancer | Non-Small Cell Lung Cancer | Science | Skin Cancer | Squamous Cell Carcinoma | Statistics | Study